Zura Bio Ltd — Director's Dealing 2025

May 22, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zura Bio Ltd (ZURA)
CIK: 0001855644
Period of Report: 2025-05-21

Reporting Person: Graham Neil Murray Hamilton (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-21	Share Option (Right to Buy)	$1.03	A	51000	Acquired	2035-05-21	Class A Ordinary Shares (51000)	Direct

Footnotes

F1: This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date.